Hot extrusion of PE/fluorouracil implantable rods for targeted drug delivery in cancer treatment
- 34 Downloads
In this study, implantable polyethylene/fluorouracil (PE/FU) rods were manufactured by hot extrusion under different processing conditions. SEM–EDS analyses revealed the effect of temperature on the morphology of the samples. Furthermore, small particles of fluorouracil were observed on the surface and in the PE matrix. Both the FTIR and NIR spectra of the PE/FU rods confirmed the presence of fluorouracil. The PE/FU rods presented lower values of flexural modulus and fatigue resistance than pure PE rods; this was probably due to imperfections and defects introduced into the PE matrix by the fluorouracil particles. The initial amount of FU released by the extruded PE/FU rods (around 35 mg/g) is desirable since it provides a high initial concentration of the drug locally to kill cancer cells following implantation. The subsequent slow and controlled release of the drug (12–45 days) provides suitable levels of the chemotherapeutic agent at the tumor site to improve the anticancer treatment.
KeywordsPolyethylene/fluorouracil Implantable rods Cancer treatment Hot extrusion Properties and drug release
The authors would like to thank PRONEX/FAPESC, CNPQ and FINEP for financial support and Mr. Paulo C.M. Rosa for the inspiration.
- 11.Maniruzzaman M, Boateng JS, Snowden MJ, Douroumis D (2013) A review of hot-meltextrusion: process technology to pharmaceutical products. Int Sch Res Netw ISRN Pharm 2012, Article ID 436763, 9 pages https://doi.org/10.5402/2012/436763
- 14.Crowley MM, Fredersdorf A, Schroeder B, Kucer S, Prodduturi S, Repka MA, McGinity JW (2004) The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. Eur J Pharm Biopharm 22:409–418Google Scholar
- 25.Eddy Christopher V, Arnold Mark A (2001) Near-infrared spectroscopy for measuring urea in hemodialysis fluids. Clin Chem 47(7):1279–1286Google Scholar
- 30.Hanafy AFAH, El-Egaky AM, Mortada SAM, Molokhia AM (2009) Development of implants for sustained release of 5-fluorouracil using low molecular weight biodegradable polymers. Drug Discov Ther 3(6):287–295Google Scholar